Immunizing teenagers is a critical part of slowing the pandemic and reaching herd immunity. But enrolling them in clinical trials poses challenges that are very different than wrangling adults.
Published: February 16, 2021 at 07:55PM
from NYT Health https://ift.tt/3dkMqo3